R&D Capabilities
Complete development of new products
This includes the development of product formulation, manufacturing process, and analytical procedures for the following dosage forms:
- Simple oral dosage forms (Immediate release (IR) tablets, Orodispersible and chewable tablets, Oral solutions, and suspensions)
- Complex solid dosage forms (Extended-Release (ER) products, Multilayer tablets, Multiparticulate system, Soft gelatin capsules)
- Transdermal (ointments and gels)
- Simple sterile liquids (Vials, ampoules, Pre-filled syringes)
- Complex injectables (Lyophilized, Extended release injectables/Injectable suspensions (excluding liposomal), Non-aqueous formulations, Emulsions)
Our capabilities also include
- Validation of manufacturing and analytical procedures/methods.
- Stability: Execute official stability batches and stability testing program.
- Documentation: Generate official documents needed for the registration of the drug product.
- Transfers: Handle project transfers to Tech transfer centers and Contract Manufacturing Organizations (CMOs).

MS Pharma has an established track record of manufacturing across a wide range of dosage forms. All our manufacturing sites are GMP accredited.

MS Pharma’s research and development centers are located in Algeria, Greece, and Jordan (2).